Experience

Jennifer Raab

    • AveXis – $95 Million IPO 


    • Cour and Takeda Partner to Treat Celiac Disease 


    • Axovant Completes $362 Million IPO 


    • Aduro Completes $137 Million IPO 


    • Ascendis Pharma closes $124 million IPO 


    • Vitae Pharmaceuticals Completes Initial Public Offering  


    • Adamas Pharmaceuticals Initial Public Offering 


    • Eagle $50 Million Initial Public Offering 


    • Genocea Biosciences IPO 


    • Two Independent Billion-Dollar Life Sciences Collaborations 


    • Onconova Therapeutics IPO 


    • Epizyme, Inc. Initial Public Offering 


    • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals